WonBiogen Co

WonBiogen Co EBITDA per Share

The EBITDA per Share of WonBiogen Co (307280.KQ) as of Oct 20, 2026 is 1,154.94 KRW. In the previous year, EBITDA per Share was 979.61 KRW — a change of 17.90% (higher).

EBITDA per Share

1,154.94KRW

YoY

17.90%

Last updated:

EBITDA per Share of WonBiogen Co is 2025 1,154.94 KRW. EBITDA per Share of WonBiogen Co was 2024 979.61 KRW. It decreases by 17.90% higher compared to the previous year.

The WonBiogen Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2020
-47.80 KRW
Jan 1, 2021
68.00 KRW
Jan 1, 2022
791.35 KRW
Jan 1, 2023
1,076.49 KRW
Jan 1, 2024
979.61 KRW
Jan 1, 2025
1,154.94 KRW
The WonBiogen Co EBITDA per Share history
YEAREBITDA per ShareYoY
1,154.94KRW+17.90%
979.61KRW-9.00%
1,076.49KRW+36.03%
791.35KRW+1,063.68%
68.00KRW-242.26%
-47.80KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

WonBiogen Co Stock analysis

What does WonBiogen Co do? WonBiogen Co Ltd, based in Gumi, South Korea, operates in the Health Care sector, focusing on the research and development of biocompatible medical materials. The company, listed on 5 December 2018, provides medical products such as wound dressings for lower leg ulcers, pressure ulcers, and surgical wounds, as well as absorbent dressings and fixation bands for bandages and catheters. WonBiogen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about WonBiogen Co stock

EBITDA per Share of WonBiogen Co is 1,154.94 KRW in 2025.

EBITDA per Share of WonBiogen Co changed from 979.61 KRW to 1,154.94 KRW, representing a 17.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share WonBiogen Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — WonBiogen Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — WonBiogen Co